Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). - Moiseyev,V.S.; Poder,P.; Andrejevs,N.; Ruda,M.Y.; Golikov,A.P.; Lazebnik,L.B.; Kobalava,Z.D.; Lehtonen,L.A.; Laine,T.; Nieminen,M.S.; Lie,K.I. (Eur Heart J, 2002)